Homely Remedies Guidance

Size: px
Start display at page:

Download "Homely Remedies Guidance"

Transcription

1 Homely Remedies Guidance Guidance from the Royal Pharmaceutical Society of Great Britain (RPSGB) in The Handling of Medicines in Social Care, states that care homes are able to purchase medicines for use within the home as homely remedies. It is emphasised however, that this must be subject to careful control. The homely remedy list should be agreed in conjunction with the service user s general medical practitioner, the community pharmacist and the home. This document has been produced as a guide to be used when developing your own Homely Remedies policy. It aims to highlight the areas which should be considered during the development process and to encourage safe working procedures and best practice. It is not intended to be used without further input from each individual care home, GP, community and Care Homes Pharmacist. Homely Remedies is another name for non-prescription medicines available for the short-term treatment of minor ailments such as indigestion, coughs, mild to moderate pain and constipation. They are usually purchased by the care home or the resident and can be administered to patients without being prescribed by a doctor. Advice from a healthcare professional, such as a GP or pharmacist, on the use of homely remedies should be taken for each resident in advance, or at the time of need. If the healthcare professional deems a patient unsuitable for treatment with any of the remedies kept within the home or decides that their clinical condition warrants early escalation rather than management with homely remedies, this should be noted in their care plan. The care plan should therefore be consulted before giving a homely remedy to any resident. Administration of homely remedies should be limited to a period of 48 hours and should be given in accordance with the patient information leaflet for each product. Any further doses required after the initial 48 hour period will necessitate discussion with the GP to re-assess the patient s condition. Any medication administered must be clearly recorded on the patient s medication administration record chart (MAR chart) and brought to the attention of the subsequent senior person on duty. The decision to administer the remedies should be made by the senior person on duty prior to each dose. The senior person must ensure that there are no contra-indications before giving the medicine to the resident, taking in to consideration any changes which may have been made to the medication regimen since the last dose. 1

2 All care home staff using a homely remedies protocol should be named in it and that they should sign to confirm they are competent to administer the medicine, acknowledging that they will be accountable for their actions. Agreement on the part of the GP to authorise the use of the homely remedies outlined in this document does not necessarily mean that they will or will not be prepared to issue a prescription if treatment is to continue. In some cases, GPs may recommend that homes purchase products overthe-counter, specifically for the use of one particular patient. Under these circumstances the medication should be labelled accordingly and should NOT be used for any other resident. Obtaining Homely Remedies 1. Homely remedies can be purchased either for an individual or for stock. A record should be kept of purchases made (see appendix 2). 2. There are two categories of homely remedy: GSL (general sales list) which are widely available from supermarkets, pharmacies and other stores; and P medicines (pharmacy) which are only available from a community pharmacy. 3. Products requiring invasive administration e.g. suppositories should not be included nor is appropriate to include products that take longer (up to 48 hours) to work e.g. lactulose. 4. External preparations should be excluded as they should only be used by one individual to avoid across contamination. 5. Dressings, items for first aid, vitamin supplements, herbal and homeopathic preparations are not homely remedies. (Note that residents may wish to purchase vitamin supplements, herbal or homeopathic preparations for their own use long-term. This should be discussed with the service user s GP and documented accordingly). Storage of Homely Remedies 1. All homely remedies MUST be stored in their original packaging together with any information supplied with the product about the medicine use. 2. Homely remedies must be stored in a locked medicine cupboard. 3. Homely remedies should be kept in an area separate from prescription medicines, in a labelled area or box within the medicine cupboard. 4. Excessive quantities of homely remedies should not be stored by care homes 5. Homely remedies should be stored at temperatures below 25ºC (unless stated otherwise) away from damp and light in accordance with the patient information leaflet or instruction on the packaging. 6. If the homely remedy is kept in a resident s room it should be stored in a lockable drawer or cupboard. 2

3 7. Access to the homely remedies should be restricted to staff with medicines management responsibilities. The policy for use should be easily accessible. 3

4 Administration of Homely Remedies The administration of a homely remedy can be in response to a request from the resident or from a member of care home staff. The National Care Forum has treatment flow charts which can be agreed locally and adapted for local use, they are available at: 1. It is the responsibility of the senior carer or duty nurse to check that the administration of the homely remedy is appropriate. If there is any uncertainty the GP or pharmacist should be consulted and the discussion documented. 2. If the resident self administers the homely remedy a risk assessment must be completed and kept with their care plan. 3. The administration of homely remedies must be recorded according to the care home policy and procedures. The resident s MAR chart should be used if it is possible. The entry should be annotated homely remedy. It should be clear what was given, when it was given, who administered it and why it was administered, as well as the effect of the medication. This is particularly important to enable staff to determine when the last dose was given, avoiding accidental overdose, and to monitor effectiveness. 4. The document used to record the purchase of the medicinal product should be updated to indicate that it has been administered to a resident (see Appendix 2). 5. Homely remedies should be given for a limited period, usually 48 hours or the period stated in the medicines policy. 6. Once opened, all liquids should have the date opened recorded on the container. Liquids should be discarded less than 6 months after opening unless otherwise stated by the manufacturer (see Care Homes SOPs 18a and 18b for details on medication disposal). Recording Homely Remedies Stock records should be kept of all homely remedies. This may be achieved by keeping a homely remedies book, with a separate section devoted to each remedy stocked (See Appendix 2). In this book records are kept of: Date obtained Quantity obtained Name of resident homely remedies given to Dose given to resident Reason for use Stock balance Date, quantity and expiry date checked by Signature of person administering and/or It is important to ensure that correct records are made both on the MAR chart and stock register. 4

5 Audit The balance and expiry dates of the homely remedies must be checked regularly. It is good practice to check these monthly. Note that some products may have a shorter shelf life once opened, check the manufacturer s literature. Disposal Expired stock should be disposed of in line with the care home s policy on the disposal of medication. (see Care Homes SOPs 18a and 18b for details on medication disposal). Review 1. The resident should be reviewed if the homely remedy is required beyond the agreed period, usually 48 hours (or 24 hours if symptoms of diarrhoea are present and fluid intake is poor), or sooner if clinically indicated. 2. If the resident is not examined by the GP but it has been agreed that treatment should continue, the GP should confirm this in writing (e.g. fax or ). Resident purchases of his/her own supply of OTC medicines. 1. OTC medicines are those which can be purchased over the counter, in a pharmacy or other retail outlet. 2. Residents and their relatives should be encouraged to inform staff of all these medicines entering the home. 3. The safety, storage and recording issues must be discussed and explained, but without invading the patient s privacy. 4. The use of such medicines is outside the scope of this guidance and separate policies should be developed by the home in conjunction with the GP and community pharmacist First aid Homely remedies should not be confused with products used for first aid. First aid boxes must comply with The Health & Safety (First Aid) Regulations

6 Developing a Homely Remedies list. This table serves as a guide for use when developing your own homely remedies list. It may be decided that items are deleted from this list and other medications added. This should be done only after full discussion and agreement with your servicing GP and Community Pharmacist. The following pages show the detail required for any medication which is subsequently added to your list (See Appendix 1). It must also be decided in conjunction with the GP how often they wish to review the medications in the homely remedies list. The local Pharmacist and GP should indicate if any chosen medication is unsuitable for any of their patients in the home, and the medication record should be annotated accordingly. Once the list has been developed, the GP, Community Pharmacist and Home representative should sign a copy of the agreement form (see Appendix 1). Minor ailment requiring treatment For aches and pains, headaches, colds, sore throats and fever. For indigestion Medicine Paracetamol 500mg Tablets OR Paracetamol 250mg/5ml Suspension Sodium alginate/ Potassium carbonate suspension Brands include: Gavison Advance and Peptac Dose 500mg-1gram every 4 to 6 hours (Maximum 4g in 24 hours) 5 to 10 ml after meals and at bedtime (Maximum 40mL in 24 hours) For coughs Simple Linctus (sugar-free) 5 to 10 ml taken 3 to 4 times daily (Maximum 40mL in 24 hours) For diarrhoea Oral Rehydration Solution One or two sachets reconstituted according to manufacturer s guidelines. Sip regularly as required. For constipation Senna 7.5mg tablets 7.5 to 15mg taken At night OR Senna 7.5mg/5mL liquid Maximum 15mg in 24 hours 6

7 NAME OF HOME. SIGNATURE OF MANAGER OF HOME.. DOCTOR NAME / PRACTICE NAME.. SIGNATURE OF DOCTOR. NAME OF CARE HOME PHARMACIST SIGNATURE OF CARE HOME PHARMACIST. DATE.. Acknowledgements: Redditch and Bromsgrove Primary Care Trust Boots the Chemist Tania Cook Medicines Management Team NHS Nottingham City CCG References: 1. RPSGB The Handling of Medicines in Social Care 2. British National Formulary No 72 September 2016-March NHS PrescQIPP Bulletin 72 Care Homes Homely Remedies August

8 Appendix 1: Example of homely remedy agreement form Care home name: GP practice name: I agree that a suitably trained senior person on duty at [insert care home name] may administer the medication listed above for the indications stated, to [insert name of patient] OR [delete one sentence as applicable] I [insert GP name] agree that a suitably trained senior person on duty at [insert care home name] may administer the medication I have authorised in this form for the indications stated, at the dose stated and for appropriate patients under my care at [insert care home name]. This agreement does not remove the requirement that staff involved in the administration of homely remedies must ensure that the medicine to be administered is suitable for the resident s particular circumstances at the time of administration. The homely remedy should not be used for longer than 48 hours without seeking medical attention. SIGNATURE OF MANAGER OF HOME.. DATE.. SIGNATURE OF DOCTOR DATE.. 8

9 Homely Remedies List Product Indication Adult dose Maximum daily dose Additional information Please indicate which products have been authorised (and annotate those that are excluded) Sodium alginate/ Potassium carbonate suspension (e.g. Gavison Advance and Peptac) For the relief of heartburn or indigestion 5 10 mls after meals and at bedtime 40mls in divided doses Sodium and potassium content should be taken into consideration if a highly restricted salt diet is recommended. Senna 7.5mg tablets For the relief of constipation 1 2 tablets (usually) at night 2 tablets May colour urine Senna syrup (7.5mg/5mL) For the relief of constipation 5 10mls (usually) at night 10mls May colour urine Paracetamol 500mg tablets (also caplets & capsules) For the relief of mild to moderate pain or raised temperature 1 or 2 tablets every 4 to 6 hours, up to a maximum of 8 in 24 hours. 4g (8 tablets) in divided doses Do not give with other paracetamol containing products. 9

10 Product Indication Adult dose Maximum daily dose Additional information Please indicate which products have been authorised (and annotate those that are excluded) Paracetamol 250mg/5ml oral suspension For the relief of mild to moderate pain or raised temperature 10 20mls every 4 6 hours, maximum of 4 doses in 24 hours. 80mls in divided doses Do not give with other paracetamol containing products. Simple linctus sugar free For dry irritating cough 5 10 mls up to 4 times a day (suitable for diabetics) 40mls in divided doses Not suitable for productive coughs. Oral rehydration sachets For treatment of fluid and electrolyte loss associated with acute diarrhoea One or two reconstituted sachet(s) after each loose motion 20-40ml/kg The solution may be refrigerated for up to 24 hours after which it should be discarded. 10

11 Paracetamol Tablets/Suspension A non-opioid drug, paracetamol is a suitable first choice for analgesia for most patients with mild to moderate pain. In normal therapeutic doses it is well tolerated and effective. It has antipyretic properties and appears to act centrally but with no anti-inflammatory effects. 1. Clinical condition / indication(s) for use i. Patients with generalised symptoms of pain ii. Fever 2. Patients eligible for inclusion in the policy: i. Any patient requesting relief from mild to moderate pain and/or fever. 3. Patients excluded from the treatment under the policy: i. Liver disease ii. Kidney disease iii. Alcohol dependence iv. Prescription of any other drugs containing paracetamol, i.e. co-dydramol, co-proxamol, co-codamol. Also check prior intake of the over-the-counter paracetamol and paracetamol containing products, especially cold and flu remedies. Over dosage with paracetamol is particularly dangerous as it may cause hepatic (liver) damage, which may not be apparent for 4 to 6 days 4. Action for patients excluded from the treatment under the policy: i. Any patient should be reviewed by medical staff and alternative medication prescribed. Discussion with the GP may also be warranted in the following situations: If pain or fever has not subsided following administration of paracetamol, or if pain increases in severity following administration of Paracetamol, notify medical staff. NB Soluble tablets have a high sodium content so should be avoided. 11

12 Sodium alginate/ Potassium carbonate suspension (e.g. Gavison Advance and Peptac) Antacids often relieve symptoms in both ulcer and non-ulcer dyspepsia and in gastro-oesophageal reflux disease. Usually given minutes after meals and at bedtime, or when required. 1. Clinical condition / indication(s) for use: i. Heartburn ii. Indigestion 2. Patients eligible for inclusion in the policy: i. Indigestion symptoms including heartburn or food-related discomfort. 3. Patients excluded from treatment under the policy: i. Any patient who might be suffering from something other than simple indigestion e.g. heart pain or severe abdominal pain; patients with recurrent/persistent symptoms; patients taking regular NSAID or aspirin or if vomiting or weight loss are present should be immediately referred to the GP ii. Patients already prescribed medicines for heartburn/indigestion eg Peptac suspension. Do not administer at the same time as other medicines as it may impair their absorption, it may also damage enteric coated (e/c) tablets. Life style advice o Reduce intake of fat, coffee, chocolate and spices. o Avoid food and drink 2-3 hours before bedtime. o Avoid smoking and alcohol. o Avoid bending and stooping. o Raise head of bed 4-6 inches. o Avoid tight abdominal clothing. Staff to note the date of opening on the bottle and dispose of after appropriate length of time (6 months after opening or manufacturers expiry datewhichever is shorter). 12

13 Simple Linctus (sugar-free) Demulcent cough preparations contain soothing substances such as syrup or glycerol. Some patients find they relieve an irritating cough especially useful during the daytime. 1. Clinical condition / indication(s) for use: i. For patients needing something soothing for irritating troublesome cough 2. Patients eligible for inclusion in the policy: i. as above 3. Patients excluded from treatment under the policy: i. not applicable 4. Action for patients excluded from treatment under the policy: i. Discuss with the GP if a troublesome cough does not subside within 24 hours. ii. GP should be consulted immediately if the patient appears mentally confused, very unwell or distressed, has one sided chest pain which is worse on coughing or deep breathing. iii. Other causes for concern include moderate to severe breathlessness, chest pain, cyanosis, pallor, asthmatic patients. Consider drug induced cough e.g. from Angiotensin Converting Enzyme Inhibitors such as Captopril, Enalapril, Lisinopril, Ramipril. Staff to note the date of opening on the bottle and dispose of after appropriate length of time (6 months after opening or manufacturers expiry datewhichever is shorter). Life style advice: o Drink plenty of fluids (but not milk or alcohol) o Use steam inhalations 2-3 times daily o Avoid cigarette smoke - patient s and other people s. Stopping smoking will help prevent future attacks 13

14 Oral Rehydration Solution There are various oral rehydration solutions available, these solutions should be reconstituted as per the manufacturer s instructions and discarded no later than 1 hour after preparation unless stored in a refrigerator when it may be kept for up to 24 hours. 1. Clinical condition / indication(s) for use: i. Diarrhoea 2. Patients eligible for inclusion in the policy: i. Patients with diarrhoea 3. Patients excluded from the treatment under the policy: i. Patients with inflammatory bowel disease. ii. Patients with active ulcerative colitis or antibiotic-associated colitis iii. Severe hepatic impairment iv. Patients with bloody diarrhoea. v. Patients with diverticular disease vi. Patients who appear severely ill or dehydrated People with diabetes 4. Action for patients excluded from treatment under the policy: i. Seek medical advice and give plenty of fluids. Life style advice: o The solution should be given in small frequent doses in sips. If symptoms last more than 24 hours then medical advice should be sought. o Diarrhoea illness outbreak within a home may indicate a more serious cause, in these situations medical advice should be sought. Recommend washing hands after using the toilet. Wash drinking glasses well. o Clear fluids only should be given for 12 hours. After 12 hours progress to high-calorie, low fibre, milk-free diet e.g: Jelly, clear soup, bread, boiled rice, porridge made with water etc. 14

15 Senna Tablets/Liquid Senna is a stimulant laxative that works within 8-12 hours, therefore it should be given at night. It increases intestinal motility and can cause abdominal cramp. Excessive use of stimulant laxatives can lead to diarrhoea. 1. Clinical conditions / indication(s) for use : i. Constipation 2. Patients eligible for inclusion in the policy : i. Patients with constipation 3. Patients excluded from treatment under the policy: i. Constipation accompanied by other symptoms, i.e. abdominal pain/vomiting, pr bleeding etc. ii. Pregnancy Urgent referral to a GP is required: iii. If constipation is associated with vomiting, loss of appetite, inability to pass wind or abdominal swelling, as these symptoms could indicate a more serious blockage (intestinal obstruction). iv. Patients who have had previous abdominal operations v. Sudden change in bowel habit and/or weight loss occur 4. Action for patients excluded from treatment under the policy: I. Discuss with GP if constipation continues or is a regular problem. Life style advice: o Increase fluid intake and fibre content of diet (Consult with Care Homes Dietician if necessary) o Increase mobility/exercise where appropriate o Ask your local pharmacist/care Homes Pharmacist/GP to review drugs to identify possible causes (painkillers containing codeine or related drugs often cause constipation). 15

16 Appendix 2: Record of homely remedies and audit sheet Name and strength of homely remedy Please use one sheet per product Date obtained Quantity obtained Date administered to resident Name of resident homely remedy administered to Dose administered to resident Administered by Balance Date, quantity and expiry date checked by NB 1. Note some products may have a shorter shelf life once opened, check the manufacturer s literature. Record the date of opening clearly on the bottle. 2. For residents who purchase they own homely remedies, record separately to those purchased and stocked by the care home 16

17 17

Care Homes - Homely Remedies Protocol

Care Homes - Homely Remedies Protocol Care Homes - Homely Remedies Protocol A homely remedy is a medicine for the short-term treatment of a minor ailment, such as indigestion, a cough, mild to moderate pain or constipation, and can be obtained

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Community Interest Company Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely

More information

Care homes - Homely remedies

Care homes - Homely remedies Bulletin 72 August 2014 Care homes - Homely remedies Care home staff have a recognised duty of care to be able to respond to minor symptoms experienced by residents. A homely remedy is a medicinal product

More information

Homely Remedies Guidance for Care Homes

Homely Remedies Guidance for Care Homes Homely Remedies Guidance for Care Homes What is a homely remedy? Homely or household remedy is another name for a non-prescription medicine which is used in a care home for the short term management of

More information

Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing

Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing Name of Care Home: Signature of Care Home Manager: Date implemented: Definition: Homely Remedies Protocol Version 4.0 For Care Homes with and without nursing A homely remedy is a product that can be purchased,

More information

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes This good practice guidance is intended to be used as a framework for care home managers to adapt when writing their

More information

Guidance on Bulk Prescribing for Care Home Residents

Guidance on Bulk Prescribing for Care Home Residents Guidance on Bulk Prescribing for Care Home Residents There are many residents in care homes taking medicines when required, which may present problems for the prescriber in determining the quantity to

More information

Guidance on Bulk Prescribing for Care Home Patients

Guidance on Bulk Prescribing for Care Home Patients Guidance on Bulk Prescribing for Care Home Patients Introduction Many patients in care homes taking medicines when required (PRN) can inevitably present problems for the prescriber in determining the quantity

More information

Over-the-counter medicines. Patient Information: Medicines. NHS Logo here. Working together for better patient information

Over-the-counter medicines. Patient Information: Medicines. NHS Logo here. Working together for better patient information Patient Information: Medicines NHS Logo here Over-the-counter medicines Health & care information you can trust The Information Standard Certified Member Working together for better patient information

More information

Homely Remedies Procedure

Homely Remedies Procedure Homely Remedies Procedure 1. Statement Homely remedies are an important part of medicines management and each home should make these available to Residents for minor and self -limiting ailments where it

More information

Homely Remedies Protocol Version 5.0 For Care Homes with and without nursing

Homely Remedies Protocol Version 5.0 For Care Homes with and without nursing Homely Remedies Protocol Version 5.0 For Care Homes with and without nursing Name of Care Home: Signature of Care Home Manager: Date implemented: Definition: A homely remedy is a product that can be purchased,

More information

GROUP PROTOCOL FOR THE MANAGEMENT OF CONSTIPATION IN PATIENTS IN CLOZAPINE CLINICS. Version 1 (reviewed unchanged January 2018)

GROUP PROTOCOL FOR THE MANAGEMENT OF CONSTIPATION IN PATIENTS IN CLOZAPINE CLINICS. Version 1 (reviewed unchanged January 2018) GROUP PROTOCOL FOR THE MANAGEMENT OF CONSTIPATION IN PATIENTS IN CLOZAPINE CLINICS Version 1 (reviewed unchanged January 2018) RATIFYING COMMITTEE Drugs and Therapeutics Group DATE ORIGINALLY 29 th October2014

More information

Medicines to treat pain in adults. Information for patients and carers

Medicines to treat pain in adults. Information for patients and carers Medicines to treat pain in adults Information for patients and carers It is common to feel some pain after having an operation (surgery), trauma or an infection. Controlling pain is an important part of

More information

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG

Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Standard Operating Procedure for Use of Opioid Transdermal Patches in homes within NHS Sutton CCG Introduction This procedure is intended to encourage good practice in the management of opioid transdermal

More information

Algorithms & Information Sheets

Algorithms & Information Sheets Minor Ailment Scheme Algorithms & Information Sheets Acute Diarrhoea Diarrhoea is an increased frequency, fluidity or volume of the bowel movements with the passage of soft and watery stools as compared

More information

Boots Fever and Pain Relief 6 Months Plus Ibuprofen 100 mg/5 ml Suspension

Boots Fever and Pain Relief 6 Months Plus Ibuprofen 100 mg/5 ml Suspension Information for the user Boots Fever and Pain Relief 6 Months Plus Ibuprofen 100 mg/5 ml Suspension Read all of this leaflet carefully because it contains important information for you. This medicine is

More information

Homely Remedies Guide

Homely Remedies Guide Homely Remedies Guide Adapted from National Care Forum Homely Remedies Guide Approved by: Wirral Medicines Management Committee Date: January 2018 Review date: January 2020 1 Contents Principles of managing

More information

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl Consumer Medicine Information Tablets and Suppositories Bisacodyl What is in this leaflet 1. What is used for 2. Before you use a) When you must not use b) Before you start to use c) Pregnancy d) Breastfeeding

More information

The Health Centre, Market Square, Stony Stratford, Milton Keynes, MK11 1YA Tel Fax

The Health Centre, Market Square, Stony Stratford, Milton Keynes, MK11 1YA Tel Fax Keep Well this Winter Prevention is Better than Cure It s Flu Jab time again! Annual flu vaccination is available free to the following high-risk people, to protect them from flu: people aged 65 or over

More information

AUGMENTIN is also used to prevent infection from major surgery.

AUGMENTIN is also used to prevent infection from major surgery. Injection Potassium clavulanate/amoxicillin sodium equivalent to 100 mg clavulanic acid/500 mg amoxicillin Potassium clavulanate/amoxicillin sodium equivalent to 200 mg clavulanic acid/1 g amoxicillin

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017

Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Agenda Item: 16 NHS Norwich CCG Governing Body Tuesday 25 th July 2017 Subject: Presented By: Submitted To: Purpose of Paper: Self-care for Self-Limiting Conditions Policy Karen Watts, Director of Quality

More information

Bisacodyl Laxative (Pharmacy Health)

Bisacodyl Laxative (Pharmacy Health) Bisacodyl Laxative (Pharmacy Health) Each Enteric Coated Tablet contains 5 mg Bisacodyl BP/Ph. Eur Gastro resistant Tablets What is in this leaflet This leaflet answers some common questions about Bisacodyl

More information

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of

More information

Day Cold & Flu Relief Oral Solution (Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride)

Day Cold & Flu Relief Oral Solution (Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride) Information for the user Day Cold & Flu Relief Oral Solution (Paracetamol, Pholcodine, Pseudoephedrine Hydrochloride) Read all of this leaflet carefully because it contains important information for you.

More information

APOHEALTH Diarrhoea Relief PLUS

APOHEALTH Diarrhoea Relief PLUS APOHEALTH Diarrhoea Relief PLUS Chewable Tablets Contains the active ingredient Loperamide hydrochloride and Simethicone Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195

More information

Information leaflet for parents and Carers. Pain Relief after Surgery

Information leaflet for parents and Carers. Pain Relief after Surgery Information leaflet for parents and Carers Pain Relief after Surgery This leaflet gives important information about your child s pain relief medicines and how to give them safely after surgery. It is important

More information

PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11. Administration

PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11. Administration PROCEDURE: SABP/EXECUTIVE BOARD/0017/PROCEDURE 11 NAME OF PROCEDURE: REASON FOR THE PROCEDURE: WHAT THE PROCEDURE WILL ACHIEVE: Medicines Procedure: Homely Remedies Administration Guidance on administration

More information

DULCOLAX Tablets and Suppositories Bisacodyl

DULCOLAX Tablets and Suppositories Bisacodyl New Zealand Consumer Medicine Information DULCOLAX Tablets and Suppositories Bisacodyl What is in this leaflet This leaflet answers some common questions about DULCOLAX. It does not contain all available

More information

Discharge from day surgery

Discharge from day surgery Discharge from day surgery Exceptional healthcare, personally delivered Discharge home You will be given verbal information about wound care and pain relief and there is written information later in this

More information

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea.

Dyspepsia. Dyspepsia covers upper abdominal pain, fullness, early satiety, bloating, and nausea. Antacids Hawler medical university Collage of pharmacy/ fourth year /pharmacy practice Sham A. Talat Shareef (B.Sc. Msc. clinical pharmacy) 2017-2018 Sham_talat@yahoo.com Head of Department Of Clinical

More information

Pain relief to take home after your surgery

Pain relief to take home after your surgery Pain relief to take home after your surgery Information for patients from the Department of Anaesthesia This factsheet explains: About pain and pain relief at home after surgery. Which pain relief drugs

More information

Pain relief at home. Information for patients, families and carers

Pain relief at home. Information for patients, families and carers Pain relief at home Information for patients, families and carers 3 Contents Page 2 Page 3 Page 4 Page 5 Page 7 Page 8 Introduction to pain relief Common pain relief medicines and their side effects More

More information

Dulcolax 5 mg, film-coated tablets

Dulcolax 5 mg, film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution Read all of this leaflet carefully before you give this medicine to your child because it contains important

More information

Medicines for Self Care Policy

Medicines for Self Care Policy Document purpose This policy describes the commissioning decision for medicines for self-care made by NHS Mansfield and Ashfield CCG and NHS Newark and Sherwood CCG. Version Version 1.0 Final Title Associated

More information

Pain relief after birth and while breastfeeding. Information for mothers

Pain relief after birth and while breastfeeding. Information for mothers Pain relief after birth and while breastfeeding Information for mothers Who is this leaflet for? This leaflet has been written to provide advice on suitable pain relief following the birth of your baby.

More information

Boots Decongestant Tablets with Paracetamol (Paracetamol, Pseudoephedrine Hydrochloride)

Boots Decongestant Tablets with Paracetamol (Paracetamol, Pseudoephedrine Hydrochloride) Information for the user Boots Decongestant Tablets with Paracetamol (Paracetamol, Pseudoephedrine Hydrochloride) Read all of this leaflet carefully because it contains important information for you. This

More information

CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL

CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL CODE OF PRACTICE ADMINISTRATION OF MEDICINES POLICY AND MEDICINES PROTOCOL Aims To ensure the appropriate and safe administration of medication to students while at school. To ensure the safe storage of

More information

A patient s guide to the. management of constipation following surgery

A patient s guide to the. management of constipation following surgery A patient s guide to the management of constipation following surgery This leaflet has been designed to give you more information about using laxatives after your surgery. What is constipation? After your

More information

Appropriate Use of Prescribed Oral Nutritional Supplement (ONS) in the Community

Appropriate Use of Prescribed Oral Nutritional Supplement (ONS) in the Community Appropriate Use of Prescribed Oral Nutritional Supplement (ONS) in the Community Aim This guideline sets out a recommended procedure for the identification and treatment of malnutrition to ensure Oral

More information

Pain relief after day surgery

Pain relief after day surgery Pain relief after day surgery Anaesthetics Department Patient Information Leaflet Introduction This leaflet is to help you with pain relief after you have day surgery. It gives information on: The types

More information

How Entecavir GH Works

How Entecavir GH Works entecavir monohydrate tablets ENTECAVIR GH Tablets Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking. This leaflet answers some common questions about. It

More information

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000 Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000

More information

MINOR AILMENTS POLICY

MINOR AILMENTS POLICY MINOR AILMENTS POLICY Whole Trust? No Statutory? Yes Website? Yes and a hard copy will be provided on request Reviewed: April 2018 Next: April 2019 MINOR AILMENTS POLICY AT PRIOR PARK COLLEGE. Prior Park

More information

Promotion of Self Care Briefing Document

Promotion of Self Care Briefing Document RCCG/GB/17/035 Promotion of Self Care Briefing Document 1. Introduction The proposal aims to promote self-care through the purchasing of medications and products from local pharmacies for the treatment

More information

Pain relief after caesarean section. Information for patients Royal Hallamshire Hospital, Jessop Wing

Pain relief after caesarean section. Information for patients Royal Hallamshire Hospital, Jessop Wing Pain relief after caesarean section Information for patients Royal Hallamshire Hospital, Jessop Wing Pain relief in the postnatal period Introduction This information leaflet has been written to give you

More information

Methotrexate. Information for patients. Paediatric Rheumatology. Feedback

Methotrexate. Information for patients. Paediatric Rheumatology. Feedback Feedback We appreciate and encourage feedback. If you need advice or are concerned about any aspect of care or treatment please speak to a member of staff or contact the Patient Advice and Liaison Service

More information

Prescribing Guidelines for Oral Nutritional Supplements (ONS) for adults

Prescribing Guidelines for Oral Nutritional Supplements (ONS) for adults Worcestershire Area Prescribing Committee Prescribing Guidelines for Oral Nutritional Supplements (ONS) for adults September 2017 Review Date September 2020 Version 3.0 1 Version Control: Version Type

More information

Do Not Reproduce. Things to Tell Your Health Care Provider

Do Not Reproduce. Things to Tell Your Health Care Provider Note: This CareKit does not replace expert medical care. 2 Things to Tell Your Health Care Provider Before medicine is prescribed, tell him or her: Medicines on your health plan s preferred drug list (formulary).

More information

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free Package leaflet: Information for the user Compound Macrogol Oral Powder Sugar Free Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Erlotinib (Tarceva )

Erlotinib (Tarceva ) Erlotinib (Tarceva ) Erlotinib (Tarceva ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C

Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Sofosbuvir, Pegylated Interferon and Ribavirin for the Treatment of Hepatitis C Department of Hepatology Digestive Diseases Centre Patient Information This leaflet is designed to give you important information

More information

Sirolimus 1mg/1ml oral solution

Sirolimus 1mg/1ml oral solution Great Ormond Street Hospital for Children NHS Foundation Trust: Information for Families Sirolimus 1mg/1ml oral solution You should read this information sheet in conjunction with any patient information

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Why you should read this leaflet This leaflet will give you the information necessary to manage your

More information

Eloxatin Oxaliplatin concentrated solution for injection

Eloxatin Oxaliplatin concentrated solution for injection Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common

More information

GROUP PROTOCOL FOR THE MANAGEMENT OF SYMPTOMS OF COUGHS. Version 5 December 2017

GROUP PROTOCOL FOR THE MANAGEMENT OF SYMPTOMS OF COUGHS. Version 5 December 2017 GROUP PROTOCOL FOR THE MANAGEMENT OF SYMPTOMS OF COUGHS Version 5 December 2017 RATIFYING COMMITTEE Drugs and Therapeutics Group DATE RATIFIED MAUP EXPIRES December 2020 EXECUTIVE SPONSOR Chief Nurse MAUP

More information

Pazopanib (Votrient ) oral for renal tumours

Pazopanib (Votrient ) oral for renal tumours Pazopanib (Votrient )oral for renal tumours Pazopanib (Votrient ) oral for renal tumours This leaflet is offered as a guide to you and your family. Pazopanib (Votrient ) is a type of medicine called a

More information

Oral anti-cancer treatment

Oral anti-cancer treatment Oral anti-cancer treatment Information for patients Chemotherapy Name Hospital No Your consultant is Anti-cancer treatment is the term used to describe medicines used to treat cancer, including chemotherapy.

More information

Chronic Obstructive Pulmonary Disease. Information about medication and an Action Plan to use if your condition gets worse due to an infection

Chronic Obstructive Pulmonary Disease. Information about medication and an Action Plan to use if your condition gets worse due to an infection Chronic Obstructive Pulmonary Disease Information about medication and an Action Plan to use if your condition gets worse due to an infection Information about your medication Your usual treatment Inhalers

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets Read all of this leaflet carefully because it contains important

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User Package Leaflet: Information for the User KLEAN-PREP 69g Sachet Powder for Oral Solution Macrogol 3350, Sodium sulphate anhydrous, Sodium bicarbonate, Sodium chloride and Potassium chloride Read all of

More information

Understanding your take home medications from the surgical ward. Information for Patients

Understanding your take home medications from the surgical ward. Information for Patients Understanding your take home medications from the surgical ward Information for Patients i Information for Patients Please read this leaflet before taking the medications that have been prescribed for

More information

Pain relief for your child after surgery

Pain relief for your child after surgery Great Ormond Street Hospital for Children NHS Trust: Information for Families Pain relief for your child after surgery When coming into hospital, children and their families are often worried that they

More information

Good Practice Guidance on Covert Administration of Medication

Good Practice Guidance on Covert Administration of Medication Good Practice Guidance on Covert Administration of Medication This good practice guidance is intended to be used as a framework for care home managers and domiciliary care providers in drawing up their

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen Sugar Free 125mg/5ml and 250mg/5ml Powder for Oral Solution Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking this medicine

More information

Brook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs

Brook Green Centre for Learning. Policy and Guidance for Supporting Pupils with Medical Needs Brook Green Centre for Learning Policy and Guidance for Supporting Pupils with Medical Needs This document was written in line with recommendations made in the DfE s information pack Supporting Pupils

More information

Colofac mebeverine hydrochloride

Colofac mebeverine hydrochloride Colofac mebeverine hydrochloride Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Colofac. It does not contain all the available information.

More information

Mycophenolate. Information for Parents/Carers

Mycophenolate. Information for Parents/Carers Mycophenolate Information for Parents/Carers St Michael s C Ward 01 878 4258 01 878 4431 Main Hospital Number 01 878 4200 What is mycophenolate and what is it used for? Mycophenolate is an immunosuppressant

More information

Self-care information on indigestion

Self-care information on indigestion Self-care information on indigestion 2 What is indigestion? Indigestion (also known as dyspepsia) is a term which describes pain or discomfort in your chest or stomach. What causes indigestion? It is caused

More information

TOFACITINIB PATIENT INFORMATION ON. (Brand name: Xeljanz ) What is tofacitinib? Important things to remember

TOFACITINIB PATIENT INFORMATION ON. (Brand name: Xeljanz ) What is tofacitinib? Important things to remember PATIENT INFORMATION ON TOFACITINIB (Brand name: Xeljanz ) This information sheet has been produced by the Australian Rheumatology Association to help you understand the medicine that has been prescribed

More information

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules. PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg Please read this leaflet carefully before taking LANCAP capsules. Keep this leaflet. You may need to read it again. If you have any further questions,

More information

Dry Cough & Congestion Relief Oral Solution

Dry Cough & Congestion Relief Oral Solution Information for the user Dry Cough & Congestion Relief Oral Solution Dextromethorphan Hydrobromide 10 mg/5 ml, Pseudoephedrine Hydrochloride 30 mg/5 ml Read all of this leaflet carefully because it contains

More information

Ibuprofen 3 Months Plus 100 mg/5 ml Suspension Strawberry Flavour

Ibuprofen 3 Months Plus 100 mg/5 ml Suspension Strawberry Flavour Information for the user Ibuprofen 3 Months Plus 100 mg/5 ml Suspension Strawberry Flavour Read all of this leaflet carefully because it contains important information for you. This medicine is available

More information

Pantoprazole (as sodium sesquihydrate) enteric coated tablets

Pantoprazole (as sodium sesquihydrate) enteric coated tablets SOZOL Consumer Medicine Information Pantoprazole (as sodium sesquihydrate) enteric coated tablets What is in this leaflet? This leaflet answers some common questions about SOZOL. It does not contain all

More information

FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation

FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation FLIXOTIDE ACCUHALER Fluticasone propionate 50, 100, 250 micrograms per inhalation Consumer Medicine Information Please read this leaflet carefully before you start taking Flixotide What is in this leaflet?

More information

Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate

Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate Chemists Own Strong Pain Extra Paracetamol and Codeine Phosphate Consumer Medicine Information(CMI) Please read this information before you start taking this medicine. What is in this CMI? This CMI answers

More information

Pain Management after Discharge from Hospital

Pain Management after Discharge from Hospital Pain Management after Discharge from Hospital South Tyneside Anaesthetics Department and Acute Pain Services 1 Part of: South Tyneside and Sunderland Healthcare Group 2 Information for patients This leaflet

More information

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally.

Afatinib (Giotrif ) Your treatment Your doctor has prescribed you a treatment called afatinib (Giotrif ) which is a tablet and is taken orally. Afatinib (Giotrif) Afatinib (Giotrif ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the cancer

More information

of LDL and HDL cholesterol.

of LDL and HDL cholesterol. Ezetimibe Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. It does not take the place of talking

More information

Buprenorphine Patch (Transtec Patch)

Buprenorphine Patch (Transtec Patch) NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Buprenorphine Patch (Transtec Patch) For the Treatment of Pain Contents Page What is a transtec patch?...

More information

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000 Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

How to Prepare for your. Colonoscopy using. Bowel Preparation YOUR QUESTIONS ANSWERED

How to Prepare for your. Colonoscopy using. Bowel Preparation YOUR QUESTIONS ANSWERED How to Prepare for your Colonoscopy using Bowel Preparation YOUR QUESTIONS ANSWERED Page 1 of 10 Page 2 of 10 Contents Introduction Page 3 What is the bowel preparation? Page 3 What can I expect? Page

More information

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) James Paget University Hospitals NHS Foundation Trust Great Yarmouth and Waveney Clinical Commissioning Group HealthEast Chronic Obstructive Pulmonary Disease (COPD) Information and Advice for Patients

More information

Patient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018

Patient Group Direction for Doxycycline (Tetracycline) Version: 01 Start Date: October 2015 Expiry Date: October 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG Lancashire North CCG Fylde & Wyre CCG East Lancashire CCG Change history Version

More information

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Package leaflet: Information for the user Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol) Read all of this leaflet carefully before you start taking this medicine because

More information

Gastro-Oesophageal Reflux Disease Information Sheet

Gastro-Oesophageal Reflux Disease Information Sheet Gastro-Oesophageal Reflux Disease Information Sheet Gastro-Oesophageal Reflux Disease This sheet gives you information about Gastro-Oesophageal Reflux Disease & Fundoplication Surgery What is gastro-oesophageal

More information

Use of steroids in neurological conditions. Information for patients Pharmacy

Use of steroids in neurological conditions. Information for patients Pharmacy Use of steroids in neurological conditions Information for patients Pharmacy The information in this leaflet is about a group of medicines called steroids, which includes medicines such as prednisolone,

More information

Ibrutinib (Imbruvica )

Ibrutinib (Imbruvica ) Ibrutinib (Imbruvica) Ibrutinib (Imbruvica ) This leaflet is offered as a guide to you and your family. Ibrutinib is a type of anti-cancer treatment called a targeted therapy. The aim of this treatment

More information

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine.

PHENYLEPHRINE. Please read this leaflet and the label of the medicine you purchased, carefully before you start using Phenylephrine. What is in this leaflet PHENYLEPHRINE New Zealand Consumer Medicine Information The medicine you have purchased contains Phenylephrine. This leaflet is intended to provide information on the active ingredient

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

HOUSEHOLD REMEDIES. Symptom Medicine Dose Frequency. Gaviscon Advance Oral Suspension. Paracetamol Tablets. Simple Linctus (sugar free)

HOUSEHOLD REMEDIES. Symptom Medicine Dose Frequency. Gaviscon Advance Oral Suspension. Paracetamol Tablets. Simple Linctus (sugar free) Woodchurch House HOUSEHOLD REMEDIES POLICY : P-48 Issue Date 15/05/16 Issue No 5 Page 1 of 2 This home understands a domestic medicine to refer to a medicine that can be bought over the counter to treat

More information

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis

More information

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet

Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet Page 1 of 6 Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet What type of drug is it? BuTrans transdermal patches

More information

1. What Solpadol is and what it is used for

1. What Solpadol is and what it is used for PATIENT INFORMATION LEAFLET SOLPADOL 30mg/500mg CAPLETS Codeine Phosphate and Paracetamol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

GenRx Amoxycillin Suspension

GenRx Amoxycillin Suspension GenRx Amoxycillin Suspension Contains the active ingredient, amoxycillin (a-mox-i-sil'lin) For a copy of a large print leaflet, Ph: 1800 195 055 Consumer Medicine Information What is in this leaflet Read

More information

Ceclor CD cefaclor monohydrate sustained release tablets

Ceclor CD cefaclor monohydrate sustained release tablets Ceclor CD cefaclor monohydrate sustained release tablets Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Ceclor CD. It does not contain all

More information